Medicago Inc.

Medicago Inc. is a biotechnology company specializing in the development and production of plant-based vaccines and therapeutic proteins. The company is headquartered in Quebec City, Canada, and has facilities in the United States and Europe.

History[edit | edit source]

Medicago Inc. was founded in 1999 with the aim of utilizing the rapid and scalable production capabilities of plants to develop vaccines and therapeutic proteins. The company's name, Medicago, is derived from the genus of plants known as Medicago, which includes species such as alfalfa and clover.

Technology[edit | edit source]

Medicago Inc. uses a proprietary technology platform based on tobacco plants to produce vaccines and therapeutic proteins. This technology, known as Virus-Like Particles (VLPs), mimics the outer shell of a virus, triggering an immune response without causing disease. The company's plant-based production system allows for rapid and cost-effective production of these VLPs.

Products[edit | edit source]

Medicago Inc. has several products in various stages of development. These include vaccines for influenza, rotavirus, and norovirus, as well as therapeutic proteins for conditions such as cancer and autoimmune diseases.

Partnerships[edit | edit source]

Medicago Inc. has formed partnerships with several major pharmaceutical and biotechnology companies, including GlaxoSmithKline and Mitsubishi Tanabe Pharma. These partnerships have helped to advance the development and commercialization of the company's products.